KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Destination Xl (DXLG) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Destination Xl (DXLG) over the last 16 years, with Q4 2025 value amounting to -$236000.0.

  • Destination Xl's Change in Accured Expenses rose 8876.73% to -$236000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$1.4 million, marking a year-over-year increase of 7964.45%. This contributed to the annual value of -$7.2 million for FY2025, which is 5863.28% down from last year.
  • As of Q4 2025, Destination Xl's Change in Accured Expenses stood at -$236000.0, which was up 8876.73% from $3.6 million recorded in Q3 2025.
  • Over the past 5 years, Destination Xl's Change in Accured Expenses peaked at $6.1 million during Q4 2021, and registered a low of -$10.0 million during Q2 2024.
  • In the last 5 years, Destination Xl's Change in Accured Expenses had a median value of $1.6 million in 2021 and averaged $27700.0.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 100108.7% in 2022, then soared by 20687.09% in 2024.
  • Quarter analysis of 5 years shows Destination Xl's Change in Accured Expenses stood at $6.1 million in 2021, then plummeted by 51.47% to $3.0 million in 2022, then crashed by 56.94% to $1.3 million in 2023, then plummeted by 264.4% to -$2.1 million in 2024, then soared by 88.77% to -$236000.0 in 2025.
  • Its Change in Accured Expenses stands at -$236000.0 for Q4 2025, versus $3.6 million for Q3 2025 and -$7.4 million for Q2 2025.